Pages
Friends and Partners
- Steroids
- Buy Steroids
- Steroid Abuse
- Buy Steroids
- Anabolic Steroids
- Buy Steroids
- clenbuterol
- candle holders
Categories
Archives
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
Meta
Number of visits to the hospital or respiratory symptoms related to bronchiolitis are not reduced or improved by administration of steroids, respectively.
This finding was disclosed in a study published in the July 26 issue of the New England Journal of Medicine.
From News-Medical.Net:
The study compared hospitalization rates for 600 children between the ages of 2 months and 12 months who visited emergency rooms with moderate-to-severe bronchiolitis. Patients were treated with either a dose of dexamethasone (a glucocorticoid form of steroid medication) or a placebo and evaluated after one hour, and again at four hours. The hospital admission rate for both groups was identical at nearly 40 percent. Both groups improved during treatment, but the placebo group did as well as the group treated with active medication. The study was conducted in the emergency departments at 20 hospitals across the United States between November and April during a three-year period. Bronchiolitis is most common during the winter months.
“We learned that a commonly used treatment doesn’t work,” said Howard M. Corneli, M.D., professor of pediatrics at the University of Utah and the principal investigator on the study. “Now that we’ve demonstrated glucocorticoids aren’t effective in treating bronchiolitis, we can focus our efforts on finding better treatments and better preventive strategies.”
These findings by the Pediatric Emergency Care Applied Research Network (PECARN) are hailed by the medical community as a set of qualified advice for treating bronchiolitis, one of the most common causes of infant hospitalization.
Nathan Kuppermann, M.D., a professor of emergency medicine and pediatrics at the University of California, Davis, chair of the PECARN network’s steering committee, and the senior investigator of the study, was of the view that this study demonstrates the power of PECARN in providing answers to otherwise difficult-to-answer questions.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.